Perrigo Co. Plc (PRGO)
15.75
-0.03
(-0.19%)
USD |
NYSE |
Nov 02, 16:00
15.78
+0.03
(+0.19%)
Pre-Market: 20:00
Perrigo EPS Diluted (Quarterly) : 0.5337 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5337 |
| March 31, 2026 | -2.874 |
| December 31, 2025 | -10.22 |
| September 30, 2025 | 0.054 |
| June 30, 2025 | -0.0608 |
| March 31, 2025 | -0.0465 |
| December 31, 2024 | -0.3234 |
| September 30, 2024 | -0.128 |
| June 30, 2024 | -0.771 |
| March 31, 2024 | 0.0298 |
| December 31, 2023 | -0.2384 |
| September 30, 2023 | 0.1125 |
| June 30, 2023 | 0.0652 |
| March 31, 2023 | -0.0081 |
| December 31, 2022 | -0.1663 |
| September 30, 2022 | -0.3871 |
| June 30, 2022 | -0.4822 |
| March 31, 2022 | -0.0097 |
| December 31, 2021 | 0.0718 |
| September 30, 2021 | -0.4402 |
| June 30, 2021 | -0.4319 |
| March 31, 2021 | 0.2831 |
| December 31, 2020 | -1.29 |
| September 30, 2020 | -1.133 |
| June 30, 2020 | 0.4407 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.775 |
| December 31, 2019 | -0.1396 |
| September 30, 2019 | 0.674 |
| June 30, 2019 | 0.0659 |
| March 31, 2019 | 0.4692 |
| December 31, 2018 | 0.5972 |
| September 30, 2018 | -0.4913 |
| June 30, 2018 | 0.26 |
| March 31, 2018 | 0.57 |
| December 31, 2017 | 0.52 |
| September 30, 2017 | 0.31 |
| June 30, 2017 | -0.49 |
| March 31, 2017 | 0.50 |
| December 31, 2016 | -9.48 |
| September 30, 2016 | -11.10 |
| June 30, 2016 | -3.73 |
| March 31, 2016 | -3.70 |
| December 31, 2015 | -0.74 |
| September 30, 2015 | 1.78 |
| June 30, 2015 | -0.15 |
| March 31, 2015 | -0.16 |
| June 30, 2014 | 0.98 |
| March 31, 2014 | 0.36 |
| December 31, 2013 | -0.87 |
| September 30, 2013 | 1.18 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.221 |
| Merck & Co., Inc. | 2.044 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 88.50M |
| Revenue (Quarterly) | 1.023B |
| Total Expenses (Quarterly) | 934.30M |
| Enterprise Value | 5.244B |
| Gross Profit Margin (Quarterly) | 30.73% |
| Profit Margin (Quarterly) | 8.65% |
| Earnings Yield | -79.43% |
| Operating Earnings Yield | 12.16% |
| Normalized Earnings Yield | -21.84 |